Eric Karas, Chief Commercial Officer: ARS Pharmaceuticals SPRY Planned sale · Filed 25/03/20

Trade details

Type: Planned sale notice
Stock: ARS Pharmaceuticals SPRY
Person: Eric KarasChief Commercial Officer
Planned sale date: 25/03/20
Filed: 25/03/20

$140K to be sold

ARS Pharmaceuticals trades, last 26 weeks

What else happened in ARS Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/02/18~25/04/19

Eric Karas's recent trades

Eric KarasChief Commercial Officer
Planned saleARS Pharmaceuticals
Planned sale
ARS Pharmaceuticals
SPRY
$431.6K
100,000 sh
$431.6K
Filed 09/30
Traded 09/30
Eric KarasChief Commercial Officer
Planned saleARS Pharmaceuticals
Planned sale
ARS Pharmaceuticals
SPRY
$69.8K
14,064 sh
$69.8K
Filed 09/11
Traded 09/11
Eric KarasChief Commercial Officer
Sell10b5-1 planARS Pharmaceuticals
Sell10b5-1 plan
ARS Pharmaceuticals
SPRY
$250K
25,000 sh
$250K
Filed 06/12
Traded 06/12
Eric KarasChief Commercial Officer
Planned sale10b5-1 planARS Pharmaceuticals
Planned sale10b5-1 plan
ARS Pharmaceuticals
SPRY
$250K
25,000 sh
$250K
Filed 06/12
Traded 06/12
Eric KarasChief Commercial Officer
Sell10b5-1 planARS Pharmaceuticals
Sell10b5-1 plan
ARS Pharmaceuticals
SPRY
$254.9K
15,000 sh
$254.9K
Filed 25/07/03
Traded 25/07/01